Management of severe Covid-19 cases through Ayurveda: A Case series
Keywords:Ayurveda, Coronavirus, COVID 19, Janpadodwansa, ARDS
The rampant destruction due to COVID is going on. So far, in modern medical system, there is no proven cure for COVID-19. The only relevant literature on the treatment of corona virus disease comes from Traditional Chinese Medicine (TCM). TCM , which is widely used to control epidemics in China, is also composed of kinds of herbs similar to Ayurveda. There is reportedly a high death rate from severe COVID-19 infection requiring oxygen support. The chest severity score as assessed by computed tomography has predictive value for future outcomes in such situations. This paper is an observational (retrospective) study of COVID-19 condition of three patient receiving Ayurvedic treatment entirely without use of any allopathic drug. There is this case series of 3 patients, 32 years old male, 38 years old female and 70 years old female. These cases were managed on the principle of Sannipatika Jwar (type of fever) along with Shwas (type of respiratory illness) with administration of Hirak bhasma, Trailokya chintamani ras, Maha lakshmi vilas ras, Abhrak bhasma, Shwaskas chintamani ras, Praval pishti, Chandramrita ras, Sitopladi churna, Mahalaxmivilas ras, Sameerpannag ras, Tab Shwas kalpa and Syp Whooping for about 10 days in different combination in these patients. The treatment resulted in complete remission of almost all the signs and symptoms. The cases were followed up after next 15 days and there were no remnant symptoms. The cases also advocated for an early Ayurvedic intervention institution for COVID-19 in prevention, deterioration and complications.
How to Cite
Copyright (c) 2022 International Journal of Ayurvedic Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.